Gynae BT 2017

istant control in consecutive patients treated with radiochemotherapy

18%

SC

events 3y 5y N

36

87% 82% 217

low risk

Actuarial probability

69% 62% 177

high risk 58

38%

Log Rank test p≤0.001

Months

Low risk: 1B, 2A, 2B, 3A &N0, High risk: 2A-2B&N+, any3B4

217 177

199 134

172

142

115

80 40

97

76

54

RetroEMBRACE Outcome Sturdza et al. 2015 (unpublished)